Preclinical1 sources
5-Amino-1MQ
Metabolic health
Small-molecule NNMT inhibitor; not a peptide. Adipose metabolism and metabolic dysfunction in experimental models.
Not FDA-approved
Integrated Wellness · The science, in context
Molecule
Library.
Understand the molecule. Question the claim.
Explore peptides and related molecules through mechanisms, published research and what we still don’t know. Clear science. No sales. No shortcuts.
A better research lens
Not all evidence is equal.
A promising mechanism is the beginning of a question—not the end of one.
01
Cells & models
What might happen?
02
Human studies
What happens in people?
03
Clinical outcomes
Does it meaningfully help?
04
Regulatory context
For which product and use?
35 molecule profiles10 research categoriesSource-linked. Education only.
A more visual way to learn
Take a trail. Trace a pathway.
Start with recovery, metabolism or longevity. Build your vocabulary, explore the biology and keep track of what you’ve read.
The research directory
Find a molecule. Follow the evidence.
9 of 35 molecules
Human research1 sources
AOD-9604
Metabolic health
Modified growth-hormone fragment. Whether a GH-derived fragment can influence lipid metabolism without reproducing all GH effects.
Not FDA-approved
Human research1 sources
CagriSema
Metabolic health
Investigational semaglutide–cagrilintide combination. Combined GLP-1 and amylin signaling for metabolic outcomes.
Not FDA-approved
Human research1 sources
Cagrilintide
Metabolic health
Long-acting amylin analog. Appetite regulation and body-weight outcomes in controlled studies.
Not FDA-approved
Preclinical1 sources
MOTS-c
Metabolic health
Mitochondrial-derived 16-amino-acid peptide. Metabolic stress, insulin sensitivity and skeletal-muscle signaling.
Not FDA-approved
Human research1 sources
Retatrutide
Metabolic health
Investigational triple-receptor agonist. Body-weight and metabolic outcomes in controlled trials.
Not FDA-approved
Human outcomes3 sources
Semaglutide
Metabolic health
GLP-1 receptor agonist. Glycemic, weight and cardiovascular outcomes in defined patient groups.
FDA-approved products · specific indications
Human outcomes1 sources
Tesamorelin
Metabolic health
GHRH analog. Visceral adipose tissue in adults with HIV-associated lipodystrophy.
FDA-approved product · narrow indication
Human outcomes2 sources
Tirzepatide
Metabolic health
Dual GIP/GLP-1 receptor agonist. Glycemic and weight outcomes and other labeled disease-specific outcomes.
FDA-approved products · specific indications
Entries may appear in more than one category. Category placement describes research interest, not proven benefit. This is a curated selection, not a systematic review; source gaps are identified inside each profile.
Beyond the library
Turn better questions into a thoughtful conversation.
Explore our broader health optimization approach. A library entry does not mean a molecule is offered, prescribed, or appropriate for you.
Request an Optimization Consultation
Continue to our existing activation & intake page.